Acomplia Augments the Age Old Theory of Obesity Reduction

Obesity as such is defined as a disease by the medical community. Though there are certain theories on what causes obesity there has been no concrete proof of it. Thus the theories related to the obesity are vague in nature. To move out of obesity there can be no better method than the age old theory of controlled dieting and physical exercises. But the process is time consuming so many a people leave it for the sake of other options like diet pills, fat burning pills, surgery, liposuction, acupressure and acupuncture. Eating habits, lack of exercises, general lethargy and heredity are considered to be some the important factors which contribute to form fat inside your body. Fat burning pills are for short term use only and if you discontinue it the fats come up again. Surgery and liposuction are costly plus the effects of it are limited. With acupressure and acupuncture the results have not been up to the mark. So, the best option left is the combination of diet pill with restricted diet program and physical exercises. And the latest weight loss diet pill is Acomplia (Rimonabant). It has been developed by Sanofi-Aventis. It is does not make one loose weight rather it makes him to have a low appetite. And as appetite gets lower his food intake too lowers. Acomplia is a new kind of drug named CB1 blocker. It blocks CB1 receptors in the brain and in near by organs which are important for lipid and glucose metabolism, adipose tissue, gastrointestinal tract, and the liver. CB1 receptor plays a vital role in regulating body weight and controlling energy balance. Acomplia (Rimonabant) is now available for sale in the UK and EU but it is not available for sale in US as it has not been approved by FDA. Though the manufacturer of Acomplia (Rimonabant) instruct of taking a pill a day, the instruction of a doctor should be followed in case of its medication. Pregnant women, breast feeding women and children should avoid this medicine unless prescribed by the doctor. An individual with a history of blood pressure, heart disease, lung disease, asthma, diabetes or allergy must tell his medical history to the doctor. Acomplia has mild and short-term side effects like – nausea, dizziness, depression and irritability. As the drug is new other side effect too may come up. In case of side effects one should consult his or her doctor. He is the right person to advice you in that regard. No medicine has been useful in treating a disease unless instructions are followed. That applies in case of Acomplia too. It is only the exercises and restricted diet which will guide you to a bright and healthy future. Acomplia is only for fastening the pace of the weight loss.

Acomplia is Waiting For The Test For Time in The UK and EU

Title:
Acomplia is Waiting For The Test For Time in The UK and EU

Word Count:
390

Summary:
Acomplia (Rimonabant) is the latest weight loss drug developed by French pharmaceutical major Sanofi-Aventis. It has been introduced in UK and EU market and is pending FDA approval for sale in US. As the drug is new the result of its effect remains to be seen.


Keywords:
Acomplia, Weight loss drug, weight loss pills, Acomplia (Rimonabant), Cheap Diet Pills, Phentermine, Acomplia treatment


Article Body:
Acomplia (Rimonabant) was approved for sale in the UK on June which means the introduction of this drug is new. Acomplia has not yet got FDA (Food and Drug Administration) approval for sale in the US. Sanofi-Aventis is the manufacturer of Acomplia, which is a French pharmaceutical firm. The drug is prescribed for suppressing appetite in an obese person. The suppression of appetite helps in lowering calorie intake thereby reducing obesity. During its trial period the manufacturer also claimed of this drug having smoking cessation effect.

As the introduction of this drug is new the success of this drug remains to be seen. But the real problem is the availability of the drug. At present only a few numbers of pharmacies are keeping it with them as FDA has not approved its use as a weight loss pill. Till the moment when FDA approves the drug, the pharmacies in US would be having tough time assuring the customers of its arrival soon.

The clinical results of Acomplia (Rimonabant) for 2 years showed much promise for this new weight loss drug. In the clinical trials around 40% of the sample lost 10% or more weight as a result of taking the drug. Apart from that the cardiovascular and metabolic risk factors related to obesity are minimised. These all are leading to a wide spread notion that Acomplia would help an obese person get slimmer when taken. The initial results of the effects of Acomplia from EU and UK is satisfactory to Sanofi-Aventis standards. But the success stories which are remaining to be unfolded from UK and EU where it has been launched last month, would only state whether this diet pill Acomplia would stand the test of time.

Howsoever successful the effects of Acomplia may be as a weight loss pill there certainly would be some side effects like nausea, dizziness, insomnia and stomach upset etc. which a user might have to deal with. But the side effects have much lower intensity than other similar diet pills. The pill must be taken with consultation of a doctor to get its maximum effect on weight loss. A person with heart disease, blood pressure, diabetes, allergy and hypertension should tell a doctor first before going for the drug. Children, pregnant woman and breast feeding mothers too should consult doctor if they are to take the pill.